Patricio Massera, AGC Biologics CEO

AGC un­veils Ger­man ex­pan­sion plans as gene and cell ther­a­py man­u­fac­tur­ing com­pe­ti­tion heats up

AGC Bi­o­log­ics is sig­nif­i­cant­ly ex­pand­ing a Ger­man site fo­cus­ing on cell and gene ther­a­pies.

The Seat­tle com­pa­ny will add an­oth­er cGMP man­u­fac­tur­ing line at its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.